The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Binary oncolytic adenovirus in combination with HER2-specific autologous CAR VST for treatment of advanced HER2-positive solid tumors (VISTA).
 
Shalini Makawita
Patents, Royalties, Other Intellectual Property - Patent for graduate school work at University of Toronto/Health Network in Toronto, Canada (patent number: WO2013134860A1) filed in 2013 on serum protein cancer biomarkers. (Inst)
 
Jerry M Gibbs
No Relationships to Disclose
 
Dustin R. McFadden
No Relationships to Disclose
 
Caroline Porter
Consulting or Advisory Role - Tessa Therapeutics
 
Amanda Rosewell Shaw
No Relationships to Disclose
 
Catherine Robertson
No Relationships to Disclose
 
Mae Louise Woods
No Relationships to Disclose
 
Tao Wang
No Relationships to Disclose
 
Bambi J Grilley
Employment - QB Regulatory Consulting; South TexAs Nuclear pharmAcy (I)
 
Helen E Heslop
Stock and Other Ownership Interests - Allovir; Fresh Wind Biotechnologies; Marker Therapeutics
Consulting or Advisory Role - GlaxoSmithKline; Kiadis Pharma; Marker Therapeutics; Mesoblast; Takara Bio; Tessa Therapeutics
Research Funding - Cell Medica (Inst); Tessa Therapeutics (Inst)
 
Malcolm K Brenner
Stock and Other Ownership Interests - Abintus Bio; Allogene Therapeutics; Allovir; Bellicum Pharmaceuticals; Bluebird Bio; Brooklyn ImmunoTherapeutics; Marker Therapeutics; Memgen; poseida therapeutics; Tessa Therapeutics; TScan Therapeutics; Turnstone Bio; Walking Fish Therapeutics
Honoraria - Merck (I)
Consulting or Advisory Role - Abintus Bio; Adaptimmune; Alimera Sciences; AstraZeneca; Athenex; Bellicum Pharmaceuticals; Bluebird Bio; Cell Medica (I); Coya; Formula Pharmaceuticals; Marker Therapeutics; Memgen; NantWorks; Onkimmune; poseida therapeutics; Tessa Therapeutics; torque; TScan Therapeutics; Turnstone Bio; Turnstone Bio; Walking Fish Therapeutics
Research Funding - Cell Medica (I)
Patents, Royalties, Other Intellectual Property - Not applicable because its not related
Travel, Accommodations, Expenses - Bluebird Bio; Merck (I); Tessa Therapeutics; Torque
 
Masataka Suzuki
Consulting or Advisory Role - Tessa Therapeutics
Research Funding - AstraZeneca; Tessa Therapeutics